Rapid Micro Biosystems, Inc. (RPID)
RPID Stock Price Chart
Explore Rapid Micro Biosystems, Inc. interactive price chart. Choose custom timeframes to analyze RPID price movements and trends.
RPID Company Profile
Discover essential business fundamentals and corporate details for Rapid Micro Biosystems, Inc. (RPID) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
15 Jul 2021
Employees
163.00
Website
https://www.rapidmicrobio.comCEO
Robert G. Spignesi Jr.
Description
Rapid Micro Biosystems, Inc. operates as a life sciences technology firm, supplying advanced solutions for identifying microbial impurities in the production processes of pharmaceuticals, medical devices, and personal care goods across North America, Europe, and Asia. Central to their offerings is the Growth Direct platform, a comprehensive system comprising the Growth Direct instrument, specialized disposable components, software for seamless integration with laboratory information management systems (LIMS), and extensive customer validation and support services. This innovative platform is designed to automate and modernize traditional, labor-intensive microbial quality control (MQC) testing workflows, which are critical for diverse therapeutic modalities such as biologics, vaccines, cutting-edge cell and gene therapies, and sterile injectable medications. Beyond their core product, the company also delivers essential services, including system installation, verification, expert technical training, and continuous support. Their technologies are widely applied in vital areas like environmental monitoring, water quality testing, bioburden assessment, and final sterility release evaluations. Established in 2006, the company initially traded as Genomic Profiling Systems, Inc., before rebranding to Rapid Micro Biosystems, Inc. in January 2007, and maintains its headquarters in Lowell, Massachusetts.
RPID Financial Timeline
Browse a chronological timeline of Rapid Micro Biosystems, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 Aug 2026
EPS estimate is -$0.26, while revenue estimate is $7.88m.
Earnings released on 13 May 2026
EPS came in at -$0.31 falling short of the estimated -$0.25 by -24.00%, while revenue for the quarter reached $8.00m , beating expectations by +5.29%.
Earnings released on 12 Mar 2026
EPS came in at -$0.28 falling short of the estimated -$0.23 by -21.74%, while revenue for the quarter reached $11.28m , missing expectations by -0.60%.
Earnings released on 7 Nov 2025
EPS came in at -$0.26 matching the estimated -$0.26, while revenue for the quarter reached $7.84m , missing expectations by -28.31%.
Earnings released on 12 Aug 2025
EPS came in at -$0.27 falling short of the estimated -$0.26 by -3.85%, while revenue for the quarter reached $7.26m , missing expectations by -12.86%.
Earnings released on 9 May 2025
EPS came in at -$0.26 surpassing the estimated -$0.27 by +3.70%, while revenue for the quarter reached $7.21m , beating expectations by +4.93%.
Earnings released on 28 Feb 2025
EPS came in at -$0.22 matching the estimated -$0.22, while revenue for the quarter reached $8.22m , beating expectations by +0.22%.
Earnings released on 1 Nov 2024
EPS came in at -$0.26 matching the estimated -$0.26, while revenue for the quarter reached $7.60m , beating expectations by +0.05%.
Earnings released on 2 Aug 2024
EPS came in at -$0.29 falling short of the estimated -$0.28 by -3.57%, while revenue for the quarter reached $6.62m , beating expectations by +1.04%.
Earnings released on 3 May 2024
EPS came in at -$0.31 falling short of the estimated -$0.29 by -6.90%, while revenue for the quarter reached $5.61m , missing expectations by -6.48%.
Earnings released on 1 Mar 2024
EPS came in at -$0.26 surpassing the estimated -$0.31 by +16.13%, while revenue for the quarter reached $6.34m , beating expectations by +15.22%.
Earnings released on 3 Nov 2023
EPS came in at -$0.31 surpassing the estimated -$0.32 by +3.13%, while revenue for the quarter reached $6.15m , missing expectations by -1.68%.
Earnings released on 4 Aug 2023
EPS came in at -$0.33 surpassing the estimated -$0.36 by +8.33%, while revenue for the quarter reached $5.00m , missing expectations by -9.87%.
Earnings released on 5 May 2023
EPS came in at -$0.32 surpassing the estimated -$0.36 by +11.11%, while revenue for the quarter reached $5.04m , beating expectations by +21.33%.
Earnings released on 3 Mar 2023
EPS came in at -$0.39 falling short of the estimated -$0.38 by -2.63%, while revenue for the quarter reached $4.37m , beating expectations by +5.91%.
Earnings released on 10 Nov 2022
EPS came in at -$0.38 falling short of the estimated -$0.37 by -2.70%, while revenue for the quarter reached $4.74m , beating expectations by +19.47%.
Earnings released on 12 Aug 2022
EPS came in at -$0.31 surpassing the estimated -$0.35 by +11.43%, while revenue for the quarter reached $3.86m , missing expectations by -11.26%.
Earnings released on 10 May 2022
EPS came in at -$0.35 falling short of the estimated -$0.33 by -6.06%, while revenue for the quarter reached $4.16m , missing expectations by -19.40%.
Earnings released on 4 Mar 2022
EPS came in at -$0.35 falling short of the estimated -$0.34 by -2.94%, while revenue for the quarter reached $5.21m , missing expectations by -11.23%.
Earnings released on 11 Nov 2021
EPS came in at -$0.39 falling short of the estimated -$0.38 by -2.63%, while revenue for the quarter reached $6.90m , beating expectations by +2.70%.
Earnings released on 26 Aug 2021
EPS came in at -$20.01 falling short of the estimated -$0.41 by -4.78k%, while revenue for the quarter reached $6.13m , missing expectations by -6.84%.
RPID Stock Performance
Access detailed RPID performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
